9BX Stock Overview
Develops and commercializes mobile electronic breathalyzers for the consumers markets, businesses, and health care providers.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Deversify Health AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0006 |
| 52 Week High | SEK 0.015 |
| 52 Week Low | SEK 0.0002 |
| Beta | 0 |
| 11 Month Change | -40.00% |
| 3 Month Change | -89.66% |
| 1 Year Change | -95.52% |
| 33 Year Change | -99.91% |
| 5 Year Change | n/a |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9BX | DE Software | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -1.0% |
| 1Y | -95.5% | 66.9% | 16.1% |
Return vs Industry: 9BX underperformed the German Software industry which returned 71.5% over the past year.
Return vs Market: 9BX underperformed the German Market which returned 18.1% over the past year.
Price Volatility
| 9BX volatility | |
|---|---|
| 9BX Average Weekly Movement | 134.6% |
| Software Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9BX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 9BX's weekly volatility has increased from 80% to 135% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Lotta Thornqvist | deversify.com |
Deversify Health AB (publ) develops and commercializes mobile electronic breathalyzers for the consumers markets, businesses, and health care providers. The company offers Acetrack, a ketone breathalyzer to determine whether a person is found to be in ketosis or not; and Elitista, a health education platform that provides customers with knowledge and tools to learn about their own metabolic health. The company is headquartered in Uppsala, Sweden.
Deversify Health AB (publ) Fundamentals Summary
| 9BX fundamental statistics | |
|---|---|
| Market cap | €23.95k |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 9BX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9BX income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 9BX perform over the long term?
See historical performance and comparison